| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 5-diphosphoinositol pentakisphosphate 1-kinase activity | 5.38e-05 | 2 | 147 | 2 | GO:0033857 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | BRIP1 POP4 CARS1 DDX56 ZNFX1 TARS2 FANCM TRMU SARS2 MLH1 DNA2 TATDN1 DHX29 GEN1 TGS1 | 8.51e-05 | 645 | 147 | 15 | GO:0140640 |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 3-kinase activity | 3.20e-04 | 4 | 147 | 2 | GO:0052724 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 1-kinase activity | 3.20e-04 | 4 | 147 | 2 | GO:0052723 | |
| GeneOntologyMolecularFunction | diphosphoinositol pentakisphosphate kinase activity | 5.31e-04 | 5 | 147 | 2 | GO:0000829 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate kinase activity | 5.31e-04 | 5 | 147 | 2 | GO:0000828 | |
| GeneOntologyMolecularFunction | inositol-1,3,4,5,6-pentakisphosphate kinase activity | 5.31e-04 | 5 | 147 | 2 | GO:0000827 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 5-kinase activity | 5.31e-04 | 5 | 147 | 2 | GO:0000832 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 1.06e-03 | 417 | 147 | 10 | GO:0140098 | |
| GeneOntologyMolecularFunction | cAMP-dependent protein kinase activity | 1.10e-03 | 7 | 147 | 2 | GO:0004691 | |
| GeneOntologyMolecularFunction | 5'-flap endonuclease activity | 1.10e-03 | 7 | 147 | 2 | GO:0017108 | |
| GeneOntologyMolecularFunction | helicase activity | 1.13e-03 | 158 | 147 | 6 | GO:0004386 | |
| GeneOntologyBiologicalProcess | neuron projection development | HECW1 MYO5B KALRN DOCK10 SEMA5A DDX56 WLS LGALS1 IGFALS DST ALMS1 SEMA5B HECW2 MYPN STAU2 FSHR TRPV2 SLITRK5 MTR LRRC7 DLX5 EIF2AK4 LGR6 IKBKB FKBP4 | 3.68e-06 | 1285 | 146 | 25 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron development | HECW1 MYO5B KALRN DOCK10 SEMA5A DDX56 WLS LGALS1 IGFALS DST ALMS1 SEMA5B HECW2 MYPN STAU2 FSHR TRPV2 SLITRK5 MTR LRRC7 DLX5 EIF2AK4 LGR6 IKBKB FKBP4 | 3.37e-05 | 1463 | 146 | 25 | GO:0048666 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | HECW1 MYO5B KALRN DOCK10 SEMA5A WLS IGFALS DST SEMA5B HECW2 MYPN STAU2 TRPV2 SLITRK5 DLX5 EIF2AK4 LGR6 | 5.45e-05 | 802 | 146 | 17 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | HECW1 MYO5B KALRN DOCK10 SEMA5A WLS IGFALS DST SEMA5B HECW2 MYPN STAU2 TRPV2 SLITRK5 DLX5 EIF2AK4 LGR6 | 7.05e-05 | 819 | 146 | 17 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | HECW1 MYO5B KALRN DOCK10 SEMA5A WLS IGFALS DST SEMA5B HECW2 MYPN STAU2 TRPV2 SLITRK5 DLX5 EIF2AK4 LGR6 | 7.83e-05 | 826 | 146 | 17 | GO:0048858 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | HECW1 MYO5B KALRN DOCK10 SEMA5A WLS IGFALS DST SEMA5B HECW2 MYPN STAU2 TRPV2 SLITRK5 DLX5 LGR6 | 8.23e-05 | 748 | 146 | 16 | GO:0048667 |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 8.52e-05 | 198 | 146 | 8 | GO:0048813 | |
| GeneOntologyBiologicalProcess | regulation of dendrite morphogenesis | 9.23e-05 | 103 | 146 | 6 | GO:0048814 | |
| HumanPheno | Pyridoxine-responsive sideroblastic anemia | 4.23e-06 | 23 | 57 | 5 | HP:0005522 | |
| HumanPheno | Absent testis | 6.57e-06 | 25 | 57 | 5 | HP:0010469 | |
| HumanPheno | Aplasia/Hypoplasia of the uvula | 1.19e-05 | 28 | 57 | 5 | HP:0010293 | |
| HumanPheno | Duodenal stenosis | 1.42e-05 | 29 | 57 | 5 | HP:0100867 | |
| HumanPheno | Small intestinal stenosis | 1.42e-05 | 29 | 57 | 5 | HP:0012848 | |
| HumanPheno | Clubbing of toes | 1.69e-05 | 30 | 57 | 5 | HP:0100760 | |
| HumanPheno | Meckel diverticulum | 2.00e-05 | 31 | 57 | 5 | HP:0002245 | |
| HumanPheno | Hypoplasia of the ulna | 2.85e-05 | 55 | 57 | 6 | HP:0003022 | |
| HumanPheno | Sideroblastic anemia | 3.69e-05 | 35 | 57 | 5 | HP:0001924 | |
| HumanPheno | Abnormal preputium morphology | 4.25e-05 | 36 | 57 | 5 | HP:0100587 | |
| HumanPheno | Aplasia/Hypoplasia of the ulna | 4.71e-05 | 60 | 57 | 6 | HP:0006495 | |
| HumanPheno | Multiple cafe-au-lait spots | 6.82e-05 | 64 | 57 | 6 | HP:0007565 | |
| HumanPheno | Abnormal ileum morphology | 1.02e-04 | 43 | 57 | 5 | HP:0001549 | |
| HumanPheno | Triphalangeal thumb | 1.23e-04 | 71 | 57 | 6 | HP:0001199 | |
| HumanPheno | Accessory phalanx of the thumb | 1.23e-04 | 71 | 57 | 6 | HP:0009619 | |
| HumanPheno | Forearm undergrowth | 1.67e-04 | 75 | 57 | 6 | HP:0009821 | |
| HumanPheno | Hydroureter | 1.93e-04 | 77 | 57 | 6 | HP:0000072 | |
| HumanPheno | High palate | TLK2 BRIP1 IPO8 STAG1 GNE CARS1 SEMA5A FANCM WLS GSC FANCD2 TRMU FANCG DST FANCI PIK3R1 HECW2 MYPN CLTC PLCH1 | 2.19e-04 | 794 | 57 | 20 | HP:0000218 |
| HumanPheno | Clubbing | 2.50e-04 | 152 | 57 | 8 | HP:0001217 | |
| HumanPheno | Bicornuate uterus | 2.55e-04 | 52 | 57 | 5 | HP:0000813 | |
| HumanPheno | Low weight | UBR1 BRIP1 STAG1 CARS1 IRF5 RRM1 FANCM FANCD2 FANCG GUF1 FANCI PIK3R1 NCAPD2 MLH1 DNA2 PPP2R3C MCTP2 | 3.28e-04 | 627 | 57 | 17 | HP:0001823 |
| HumanPheno | Abnormality of chromosome stability | 3.33e-04 | 55 | 57 | 5 | HP:0003220 | |
| HumanPheno | Upper limb undergrowth | 3.54e-04 | 86 | 57 | 6 | HP:0009824 | |
| HumanPheno | Abnormal duodenum morphology | 4.01e-04 | 88 | 57 | 6 | HP:0002246 | |
| HumanPheno | Localized skin lesion | UBR1 TRAF6 BRIP1 IPO8 SEMA5A IRF5 IDH2 FANCM WLS GSC FANCD2 FANCG DST GNA14 FANCI PIK3R1 MLH1 TRPV3 EIF2AK4 GRHL3 MCTP2 | 4.03e-04 | 897 | 57 | 21 | HP:0011355 |
| MousePheno | increased cellular sensitivity to DNA damaging agents | 2.44e-06 | 26 | 120 | 5 | MP:0014040 | |
| Domain | LRR_1 | KERA LRRC70 ERBIN IGFALS PRELP FSHR ANP32A SLITRK5 PHLPP1 LRRC7 LGR6 | 1.31e-06 | 219 | 147 | 11 | PF00560 |
| Domain | LRRNT | 3.63e-06 | 53 | 147 | 6 | PF01462 | |
| Domain | LRR | KERA LRRC70 ERBIN IGFALS PRELP ANP32A SLITRK5 PHLPP1 LRRC7 LGR6 | 4.40e-06 | 201 | 147 | 10 | PS51450 |
| Domain | LRR_8 | 8.55e-06 | 171 | 147 | 9 | PF13855 | |
| Domain | Leu-rich_rpt | KERA LRRC70 ERBIN IGFALS PRELP FSHR ANP32A SLITRK5 PHLPP1 LRRC7 LGR6 | 1.02e-05 | 271 | 147 | 11 | IPR001611 |
| Domain | LRR_TYP | 1.13e-05 | 177 | 147 | 9 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 1.13e-05 | 177 | 147 | 9 | IPR003591 | |
| Domain | LRRNT | 1.23e-05 | 98 | 147 | 7 | IPR000372 | |
| Domain | LRRNT | 1.23e-05 | 98 | 147 | 7 | SM00013 | |
| Domain | WW | 3.32e-05 | 47 | 147 | 5 | PF00397 | |
| Domain | WW | 3.68e-05 | 48 | 147 | 5 | SM00456 | |
| Domain | - | KERA LRRC70 ERBIN IGFALS PRELP FSHR ANP32A SLITRK5 PHLPP1 LRRC7 LGR6 | 4.83e-05 | 321 | 147 | 11 | 3.80.10.10 |
| Domain | WW_DOMAIN_1 | 4.95e-05 | 51 | 147 | 5 | PS01159 | |
| Domain | WW_DOMAIN_2 | 4.95e-05 | 51 | 147 | 5 | PS50020 | |
| Domain | WW_dom | 5.44e-05 | 52 | 147 | 5 | IPR001202 | |
| Domain | L_dom-like | KERA LRRC70 ERBIN IGFALS PRELP FSHR ANP32A SLITRK5 PHLPP1 LRRC7 LGR6 | 5.87e-05 | 328 | 147 | 11 | IPR032675 |
| Domain | HECW_N | 6.15e-05 | 2 | 147 | 2 | IPR032348 | |
| Domain | HECW_N | 6.15e-05 | 2 | 147 | 2 | PF16562 | |
| Domain | aa-tRNA-synt_IIb | 7.53e-05 | 11 | 147 | 3 | IPR002314 | |
| Domain | tRNA-synt_2b | 7.53e-05 | 11 | 147 | 3 | PF00587 | |
| Domain | Distal-less_N | 1.84e-04 | 3 | 147 | 2 | IPR022135 | |
| Domain | DLL_N | 1.84e-04 | 3 | 147 | 2 | PF12413 | |
| Domain | aa-tRNA-synth_II | 3.57e-04 | 18 | 147 | 3 | IPR006195 | |
| Domain | AA_TRNA_LIGASE_II | 3.57e-04 | 18 | 147 | 3 | PS50862 | |
| Domain | ARM-type_fold | 3.59e-04 | 339 | 147 | 10 | IPR016024 | |
| Domain | - | 3.65e-04 | 4 | 147 | 2 | 1.10.10.440 | |
| Domain | TRPV1-4_channel | 3.65e-04 | 4 | 147 | 2 | IPR008347 | |
| Domain | - | 4.94e-04 | 20 | 147 | 3 | 3.40.50.1240 | |
| Domain | His_PPase_superfam | 4.94e-04 | 20 | 147 | 3 | IPR029033 | |
| Domain | Spectrin | 7.54e-04 | 23 | 147 | 3 | PF00435 | |
| Domain | ACTININ_2 | 7.54e-04 | 23 | 147 | 3 | PS00020 | |
| Domain | ACTININ_1 | 7.54e-04 | 23 | 147 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 7.54e-04 | 23 | 147 | 3 | IPR001589 | |
| Domain | - | BRIP1 MYO1E ABCC5 DDX56 ZNFX1 FANCM GUF1 NWD2 GNA14 CHST4 GNA12 DNA2 DHX29 HYDIN DYNC1H1 | 8.11e-04 | 746 | 147 | 15 | 3.40.50.300 |
| Domain | FF_domain | 9.04e-04 | 6 | 147 | 2 | IPR002713 | |
| Domain | FF | 9.04e-04 | 6 | 147 | 2 | PS51676 | |
| Domain | Gphrmn_rcpt_fam | 9.04e-04 | 6 | 147 | 2 | IPR002131 | |
| Domain | FF | 9.04e-04 | 6 | 147 | 2 | PF01846 | |
| Domain | FF | 9.04e-04 | 6 | 147 | 2 | SM00441 | |
| Domain | Acid_Pase_AS | 9.04e-04 | 6 | 147 | 2 | IPR033379 | |
| Domain | P-loop_NTPase | BRIP1 MYO1E MYO5B ABCC5 DDX56 ZNFX1 FANCM GUF1 NWD2 GNA14 CHST4 GNA12 DNA2 DHX29 HYDIN DYNC1H1 | 1.06e-03 | 848 | 147 | 16 | IPR027417 |
| Domain | HECT | 1.22e-03 | 27 | 147 | 3 | PF00632 | |
| Domain | HECTc | 1.22e-03 | 27 | 147 | 3 | SM00119 | |
| Domain | HECT_dom | 1.22e-03 | 27 | 147 | 3 | IPR000569 | |
| Domain | HECT | 1.22e-03 | 27 | 147 | 3 | PS50237 | |
| Domain | HIS_ACID_PHOSPHAT_2 | 1.26e-03 | 7 | 147 | 2 | PS00778 | |
| Domain | HIS_ACID_PHOSPHAT_1 | 1.26e-03 | 7 | 147 | 2 | PS00616 | |
| Domain | ARM-like | 1.36e-03 | 270 | 147 | 8 | IPR011989 | |
| Domain | Spectrin_repeat | 1.50e-03 | 29 | 147 | 3 | IPR002017 | |
| Domain | His_Pase_clade-2 | 1.67e-03 | 8 | 147 | 2 | IPR000560 | |
| Domain | His_Phos_2 | 1.67e-03 | 8 | 147 | 2 | PF00328 | |
| Domain | C2_dom | 1.91e-03 | 164 | 147 | 6 | IPR000008 | |
| Domain | SPEC | 2.00e-03 | 32 | 147 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.00e-03 | 32 | 147 | 3 | IPR018159 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 2.60e-03 | 35 | 147 | 3 | IPR002464 | |
| Domain | - | 3.23e-03 | 11 | 147 | 2 | 3.40.50.800 | |
| Domain | DEAH_ATP_HELICASE | 3.29e-03 | 38 | 147 | 3 | PS00690 | |
| Domain | C2 | 3.80e-03 | 131 | 147 | 5 | PF00168 | |
| Domain | C2 | 4.59e-03 | 137 | 147 | 5 | SM00239 | |
| Domain | - | 4.92e-03 | 333 | 147 | 8 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 5.10e-03 | 335 | 147 | 8 | IPR015943 | |
| Domain | Anticodon-bd | 5.26e-03 | 14 | 147 | 2 | IPR004154 | |
| Domain | C2 | 5.34e-03 | 142 | 147 | 5 | PS50004 | |
| Domain | - | 6.34e-03 | 148 | 147 | 5 | 2.60.40.150 | |
| Domain | HEAT | 6.38e-03 | 48 | 147 | 3 | PF02985 | |
| Domain | GproteinA_insert | 6.87e-03 | 16 | 147 | 2 | IPR011025 | |
| Domain | - | 6.87e-03 | 16 | 147 | 2 | 1.10.400.10 | |
| Domain | G-alpha | 6.87e-03 | 16 | 147 | 2 | PF00503 | |
| Domain | G_alpha | 6.87e-03 | 16 | 147 | 2 | SM00275 | |
| Domain | SH3 | 7.32e-03 | 216 | 147 | 6 | PS50002 | |
| Domain | Gprotein_alpha_su | 7.74e-03 | 17 | 147 | 2 | IPR001019 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FANCONI_ANEMIA_PATHWAY | 1.87e-05 | 19 | 122 | 4 | M47853 | |
| Pathway | PID_FANCONI_PATHWAY | 5.13e-05 | 47 | 122 | 5 | M1 | |
| Pubmed | UBR1 DOCK10 GON4L ZNFX1 TARS2 WLS DENND3 SULF2 DST TCERG1 MLH1 MTR EIF2AK4 PPIP5K2 PLCH1 DNA2 CNOT4 | 3.28e-09 | 650 | 149 | 17 | 38777146 | |
| Pubmed | 3.91e-09 | 15 | 149 | 5 | 19536649 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | POP4 RMND5A IPO8 RAE1 PITRM1 MYO1E MYO5B ERO1A TARS2 WLS LGALS1 FANCD2 FANCI GCC2 PRKACA INTS4 DNA2 TGS1 | 4.55e-09 | 754 | 149 | 18 | 33060197 |
| Pubmed | 1.12e-08 | 7 | 149 | 4 | 24451376 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | MYO1E SWAP70 GNE ERO1A TOM1L1 CARS1 PSME2 RRM1 LGALS1 FANCD2 FANCI TLN1 ANP32A NCAPD2 PRKACA SF3A3 MTR IKBKB DNMBP TATDN1 USP15 FKBP4 DYNC1H1 VCPIP1 | 1.47e-08 | 1455 | 149 | 24 | 22863883 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DCAF1 UBR1 GNE NOC2L DOCK10 DDX56 RRM1 ERBIN LGALS1 CCNT1 GUF1 DST TCERG1 FANCI RPTOR TLN1 CLTC NCAPD2 SF3A3 MLH1 DHX29 UTRN DYNC1H1 | 1.76e-08 | 1353 | 149 | 23 | 29467282 |
| Pubmed | DCAF1 DOCK10 GON4L ERBIN ZBED4 GCC2 TLN1 CLTC PPIP5K1 LRRC7 USP15 DYNC1H1 VCPIP1 | 2.54e-08 | 407 | 149 | 13 | 12693553 | |
| Pubmed | 4.27e-08 | 23 | 149 | 5 | 20301575 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | IPO8 PITRM1 NOC2L ERO1A CARS1 DDX56 IDH2 TARS2 FANCD2 TCERG1 FANCI RPTOR TLN1 CLTC ANP32A NCAPD2 PRKACA SF3A3 MTR DHX29 FKBP4 DYNC1H1 | 1.97e-07 | 1425 | 149 | 22 | 30948266 |
| Pubmed | RMND5A IPO8 MYO1E NOC2L ERO1A DDX56 PSME2 IDH2 RRM1 ERBIN FANCD2 DST FANCI TLN1 STAU2 CLTC ANP32A NCAPD2 SF3A3 IKBKB DHX29 DYNC1H1 | 2.36e-07 | 1440 | 149 | 22 | 30833792 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DCAF1 TLK2 TRAF6 RMND5A IPO8 PITRM1 MYO1E MYO5B STYXL2 IDH2 CCNYL1 DCP1B PIK3R1 GCC2 RPTOR PRKACA SF3A3 PXMP2 PPIP5K2 USP15 DYNC1H1 | 2.39e-07 | 1321 | 149 | 21 | 27173435 |
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 26336824 | ||
| Pubmed | 4.12e-07 | 215 | 149 | 9 | 35973513 | ||
| Pubmed | 4.26e-07 | 15 | 149 | 4 | 20603015 | ||
| Pubmed | 4.39e-07 | 283 | 149 | 10 | 21903422 | ||
| Pubmed | TBC1D19 DCAF1 POP4 SWAP70 ERO1A DST TLN1 MLH1 PPIP5K2 UTRN DYNC1H1 | 4.85e-07 | 360 | 149 | 11 | 33111431 | |
| Pubmed | 5.66e-07 | 16 | 149 | 4 | 20301753 | ||
| Pubmed | 6.02e-07 | 225 | 149 | 9 | 12168954 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | SWAP70 CARS1 PSME2 RRM1 LCP1 TCERG1 TLN1 CLTC NCAPD2 SF3A3 ADAMTS20 LRRC7 DHX29 UTRN FKBP4 DYNC1H1 | 8.01e-07 | 847 | 149 | 16 | 35235311 |
| Pubmed | 1.53e-06 | 6 | 149 | 3 | 24966277 | ||
| Pubmed | 1.53e-06 | 6 | 149 | 3 | 27097374 | ||
| Pubmed | SMAP1 RAE1 HECW1 KALRN ZNFX1 IDH2 ERBIN GRK2 RPTOR STAU2 CLTC ANP32A SLITRK5 LRRC7 DAAM1 USP15 DHX29 VCPIP1 | 2.03e-06 | 1139 | 149 | 18 | 36417873 | |
| Pubmed | IPO8 RAE1 NOC2L DOCK10 CCNT1 TCERG1 FANCI PIK3R1 TLN1 ANP32A PRKACA PPIP5K2 DNMBP USP15 UTRN FKBP4 | 2.20e-06 | 916 | 149 | 16 | 32203420 | |
| Pubmed | ABCC5 RRM1 ERBIN DST TCERG1 FANCI TLN1 NCAPD2 SLITRK5 LRRC7 PLCH1 DHX29 DYNC1H1 VCPIP1 | 2.40e-06 | 708 | 149 | 14 | 39231216 | |
| Pubmed | TRAF6 STAG1 MYO1E KALRN ABCC5 ZNFX1 UBASH3A GUF1 SARS2 DST TCERG1 HECTD2 PIK3R1 CLTC CCDC15 UTRN GEN1 DYNC1H1 VCPIP1 | 2.72e-06 | 1285 | 149 | 19 | 35914814 | |
| Pubmed | PITRM1 SULF2 DST SEMA5B HECW2 RPTOR NCAPD2 EIF2AK4 DAAM1 PPIP5K2 DNA2 DNMBP | 3.26e-06 | 529 | 149 | 12 | 14621295 | |
| Pubmed | SMAP1 MYO1E MYO5B KALRN ZNFX1 IDH2 ERBIN NWD2 DST GRK2 HECW2 RPTOR TLN1 CLTC PRKACA LRRC7 PLCH1 DHX29 UTRN DYNC1H1 | 3.40e-06 | 1431 | 149 | 20 | 37142655 | |
| Pubmed | 3.59e-06 | 209 | 149 | 8 | 36779422 | ||
| Pubmed | DCAF1 BRIP1 RAE1 MYO5B CARS1 ERBIN DST FANCI PIK3R1 TLN1 CLTC MLH1 FKBP4 | 3.78e-06 | 634 | 149 | 13 | 34591612 | |
| Pubmed | DNA polymerase POLN participates in cross-link repair and homologous recombination. | 4.25e-06 | 8 | 149 | 3 | 19995904 | |
| Pubmed | 4.25e-06 | 8 | 149 | 3 | 34469738 | ||
| Pubmed | 4.57e-06 | 216 | 149 | 8 | 31519766 | ||
| Pubmed | DCAF1 IPO8 NOC2L ERO1A TARS2 RRM1 ERBIN GUF1 SARS2 PIK3R1 TLN1 STAU2 CLTC PRKACA MTR DAAM1 PLCH1 DNA2 DHX29 FKBP4 | 6.01e-06 | 1487 | 149 | 20 | 33957083 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 8.95e-06 | 313 | 149 | 9 | 38270169 | |
| Pubmed | An endothelin-1 switch specifies maxillomandibular identity. | 9.05e-06 | 10 | 149 | 3 | 19017795 | |
| Pubmed | 9.30e-06 | 31 | 149 | 4 | 19690177 | ||
| Pubmed | ERO1A DOCK10 DDX56 PSME2 GRK2 DCP1B FANCI PIK3R1 GCC2 STAU2 CLTC NCAPD2 PXMP2 MLH1 DAAM1 MCTP2 DYNC1H1 | 1.16e-05 | 1168 | 149 | 17 | 19946888 | |
| Pubmed | KALRN DCP1B FANCI GCC2 RPTOR MYPN STAU2 NCAPD2 USP15 DHX29 FKBP4 | 1.19e-05 | 503 | 149 | 11 | 16964243 | |
| Pubmed | 1.24e-05 | 11 | 149 | 3 | 20333701 | ||
| Pubmed | 1.24e-05 | 11 | 149 | 3 | 26625197 | ||
| Pubmed | 1.24e-05 | 11 | 149 | 3 | 22902530 | ||
| Pubmed | The spontaneous mouse mutant low set ears (Lse) is caused by tandem duplication of Fgf3 and Fgf4. | 1.24e-05 | 11 | 149 | 3 | 37341808 | |
| Pubmed | The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair. | 1.24e-05 | 11 | 149 | 3 | 19965384 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.57e-05 | 256 | 149 | 8 | 33397691 | |
| Pubmed | 1.65e-05 | 12 | 149 | 3 | 16116422 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RAE1 KALRN DDX56 IDH2 NWD2 SULF2 DST ZBED4 TCERG1 STAU2 CLTC SF3A3 INTS4 GNA12 PPIP5K2 DYNC1H1 | 1.76e-05 | 1082 | 149 | 16 | 38697112 |
| Pubmed | BRIP1 ERO1A WLS ERBIN ALMS1 DCP1B SF3A3 MTR PPIP5K2 PLCH1 USP15 VCPIP1 TGS1 | 1.76e-05 | 733 | 149 | 13 | 34672954 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.77e-05 | 341 | 149 | 9 | 32971831 | |
| Pubmed | Polymorphisms of the TRPV2 and TRPV3 genes associated with fibromyalgia in a Korean population. | 1.82e-05 | 2 | 149 | 2 | 27079220 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 18981179 | ||
| Pubmed | DNA clamp function of the monoubiquitinated Fanconi anaemia ID complex. | 1.82e-05 | 2 | 149 | 2 | 32269332 | |
| Pubmed | FANCI functions as a repair/apoptosis switch in response to DNA crosslinks. | 1.82e-05 | 2 | 149 | 2 | 34256011 | |
| Pubmed | FANCI protein binds to DNA and interacts with FANCD2 to recognize branched structures. | 1.82e-05 | 2 | 149 | 2 | 19561358 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 28636932 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 26637282 | ||
| Pubmed | Replication stress induces sister-chromatid bridging at fragile site loci in mitosis. | 1.82e-05 | 2 | 149 | 2 | 19465922 | |
| Pubmed | Expression and purification of human FANCI and FANCD2 using Escherichia coli cells. | 1.82e-05 | 2 | 149 | 2 | 25168188 | |
| Pubmed | Protein kinase A phosphorylates and regulates the osteogenic activity of Dlx5. | 1.82e-05 | 2 | 149 | 2 | 21406180 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 25326420 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 24278431 | ||
| Pubmed | FANCD2-FANCI surveys DNA and recognizes double- to single-stranded junctions. | 1.82e-05 | 2 | 149 | 2 | 39085614 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 20925653 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 28126903 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 32725171 | ||
| Pubmed | Mechanism, specificity, and function of FANCD2-FANCI ubiquitination and deubiquitination. | 1.82e-05 | 2 | 149 | 2 | 34137174 | |
| Pubmed | Dystonin deficiency reduces taste buds and fungiform papillae in the anterior part of the tongue. | 1.82e-05 | 2 | 149 | 2 | 17156752 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 27773793 | ||
| Pubmed | FANCI Regulates Recruitment of the FA Core Complex at Sites of DNA Damage Independently of FANCD2. | 1.82e-05 | 2 | 149 | 2 | 26430909 | |
| Pubmed | FANCJ/BRIP1 recruitment and regulation of FANCD2 in DNA damage responses. | 1.82e-05 | 2 | 149 | 2 | 20676667 | |
| Pubmed | Immune complex-induced integrin activation and L-plastin phosphorylation require protein kinase A. | 1.82e-05 | 2 | 149 | 2 | 10446213 | |
| Pubmed | Temporospatial cell interactions regulating mandibular and maxillary arch patterning. | 1.82e-05 | 2 | 149 | 2 | 10603356 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 19423727 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 32167469 | ||
| Pubmed | Novel insights into the TRPV3-mediated itch in atopic dermatitis. | 1.82e-05 | 2 | 149 | 2 | 33035568 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 15039079 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 29059323 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 31216032 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 17702752 | ||
| Pubmed | FANCI is a second monoubiquitinated member of the Fanconi anemia pathway. | 1.82e-05 | 2 | 149 | 2 | 17460694 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 25070891 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 27405460 | ||
| Pubmed | Structure of the FANCI-FANCD2 complex: insights into the Fanconi anemia DNA repair pathway. | 1.82e-05 | 2 | 149 | 2 | 21764741 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 17690096 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 11278469 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 20921626 | ||
| Pubmed | Mechanism of Ubiquitination and Deubiquitination in the Fanconi Anemia Pathway. | 2.14e-05 | 13 | 149 | 3 | 27986371 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYO1E KALRN DDX56 IRF5 SARS2 DST ZBED4 FANCI RPTOR TLN1 NCAPD2 GNA12 DLX2 DNMBP PPP2R3C DYNC1H1 | 2.28e-05 | 1105 | 149 | 16 | 35748872 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | IPO8 PITRM1 DDX56 IDH2 TARS2 FANCD2 GUF1 SARS2 DST ALMS1 PIK3R1 RPTOR STAU2 CLTC PRKACA MTR GEN1 FKBP4 VCPIP1 | 2.32e-05 | 1496 | 149 | 19 | 32877691 |
| Pubmed | POP4 NOC2L GON4L DDX56 ERBIN CCNT1 GUF1 DST TCERG1 TLN1 STAU2 NCAPD2 PRKACA MLH1 DAAM1 DNMBP SGF29 DHX29 UTRN | 2.34e-05 | 1497 | 149 | 19 | 31527615 | |
| Pubmed | 2.71e-05 | 14 | 149 | 3 | 27119228 | ||
| Pubmed | 2.71e-05 | 14 | 149 | 3 | 10601039 | ||
| Pubmed | 2.90e-05 | 203 | 149 | 7 | 35012549 | ||
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 2.94e-05 | 364 | 149 | 9 | 24778252 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | RAE1 PSME2 FANCD2 FANCI RPTOR NCAPD2 PRKACA MTR USP15 DYNC1H1 VCPIP1 | 3.81e-05 | 571 | 149 | 11 | 37167062 |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 3.82e-05 | 212 | 149 | 7 | 33853758 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | TLK2 SMAP1 TRAF6 NOC2L DDX56 LGALS1 SARS2 FANCI PIK3R1 CLTC PRKACA SF3A3 MTR LRRC7 USP15 FKBP4 DYNC1H1 | 3.85e-05 | 1284 | 149 | 17 | 17353931 |
| Pubmed | 4.14e-05 | 16 | 149 | 3 | 27760317 | ||
| Pubmed | 4.14e-05 | 16 | 149 | 3 | 24650709 | ||
| Pubmed | DCAF1 PITRM1 IDH2 TARS2 RRM1 ERBIN GUF1 SARS2 PIK3R1 RPTOR ALDH3A1 DYNC1H1 | 4.28e-05 | 686 | 149 | 12 | 28380382 | |
| Pubmed | TPTE MYO5B TARS2 ERBIN FANCD2 FANCI PIK3R1 CLTC PRKACA MLH1 PHLPP1 INTS4 EIF2AK4 UTRN FKBP4 | 4.79e-05 | 1049 | 149 | 15 | 27880917 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 5.25e-08 | 20 | 95 | 5 | 548 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.85e-04 | 36 | 95 | 3 | 823 | |
| GeneFamily | UPF1 like RNA helicases | 1.46e-03 | 11 | 95 | 2 | 1169 | |
| GeneFamily | Small leucine rich repeat proteoglycans | 1.74e-03 | 12 | 95 | 2 | 573 | |
| Coexpression | MATHEW_FANCONI_ANEMIA_GENES | 3.12e-07 | 11 | 148 | 4 | M12972 | |
| Coexpression | GSE3982_DC_VS_NEUTROPHIL_UP | 2.15e-06 | 200 | 148 | 9 | M5461 | |
| Coexpression | GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_UP | 1.89e-05 | 200 | 148 | 8 | M5627 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | TLK2 SMAP1 CCNYL1 ALMS1 SLC16A4 TCERG1 HECTD2 GCC2 CCDC15 USP15 GEN1 TGS1 | 1.95e-06 | 311 | 148 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | BRIP1 MYO1E SWAP70 IRF5 RRM1 FANCM DENND3 FANCD2 FANCI STAU2 NCAPD2 DNA2 GEN1 | 2.72e-06 | 380 | 148 | 13 | GSM538207_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | TLK2 SMAP1 MYO5B CCNYL1 ALMS1 SLC16A4 TCERG1 DCP1B SEMA5B HECTD2 GCC2 SLITRK5 CCDC15 PHLPP1 DAAM1 IKBKB PLCH1 USP15 GEN1 TGS1 | 1.81e-05 | 989 | 148 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | TLK2 POP4 FANCM CCNT1 CCNYL1 DST ALMS1 SLC16A4 TCERG1 ANP32A USP15 GEN1 TGS1 | 2.57e-05 | 469 | 148 | 13 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | DCAF1 TLK2 SMAP1 IPO8 CA14 GLB1L2 FANCM TTC6 FANCD2 CFAP54 ALMS1 ZBED4 SEMA5B HECTD2 GCC2 ANP32A CCDC15 PHLPP1 SNX31 DLX5 PLCH1 DNA2 GEN1 TGS1 | 4.37e-05 | 1414 | 148 | 24 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | DCAF1 TLK2 SMAP1 POP4 PITRM1 SEMA5A FANCM CFAP54 SULF2 CCNYL1 ALMS1 ZBED4 HECTD2 GCC2 STAU2 ANP32A MLH1 PPIP5K2 DNA2 GEN1 CNOT4 TGS1 | 5.68e-05 | 1252 | 148 | 22 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| ToppCell | Control-Control-Lymphocyte-T/NK-T/NK_proliferative|Control / Disease, condition lineage and cell class | 3.86e-07 | 200 | 149 | 8 | 6cf63dd57f6bc0c42e7182322dd24ff9afbe9186 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.26e-06 | 162 | 149 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-06 | 165 | 149 | 7 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.88e-06 | 172 | 149 | 7 | 6fcc16f1067672967ecbcdfdc727649ae9891dd9 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.90e-06 | 118 | 149 | 6 | 3f0a304ef9c9e5ba047fc09f4372590eed624328 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.63e-06 | 190 | 149 | 7 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.63e-06 | 190 | 149 | 7 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.02e-06 | 193 | 149 | 7 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Stem_cells-neuroepithelial-like_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 4.43e-06 | 127 | 149 | 6 | 9071cd0953c8bb6746dc9cd13d153e3d6ef40b08 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.45e-06 | 196 | 149 | 7 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 4.45e-06 | 196 | 149 | 7 | 36ed1918f70b6f5760bb088b15ce422998055cc7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.60e-06 | 197 | 149 | 7 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 4.60e-06 | 197 | 149 | 7 | 58b957efd006f43c2fe55071d5c6d06c2e367e72 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.60e-06 | 197 | 149 | 7 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 4.76e-06 | 198 | 149 | 7 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.92e-06 | 199 | 149 | 7 | e98ff036d04fc78dffef156bdc0d644532274067 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.92e-06 | 199 | 149 | 7 | 305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.92e-06 | 199 | 149 | 7 | 7feedb0bf84a3361c8ab5b6674ff64e8ff140c23 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.92e-06 | 199 | 149 | 7 | 123fbf2122aa221d8cbf3aef9361ba0982c07695 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.92e-06 | 199 | 149 | 7 | fba48342066aab41a8bcb20db40a6df0158e1cbe | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.92e-06 | 199 | 149 | 7 | 6b1304417cf9c44ca70d2bfc2b5acc1a206f25b6 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Mild / Disease, condition lineage and cell class | 5.08e-06 | 200 | 149 | 7 | 6126a3bbafe2110fba0c1c4493035df4e8193d22 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Severe / Disease, condition lineage and cell class | 5.08e-06 | 200 | 149 | 7 | 0892603e604c2a945dd720685d45970f855bd5d3 | |
| ToppCell | Biopsy_Control_(H.)-Immune-Proliferating_Macrophages|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.08e-06 | 200 | 149 | 7 | ce9fad55f779afd3d6c5a9c5a15e2d9f548b7c7e | |
| ToppCell | BL-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.08e-06 | 200 | 149 | 7 | 04d95a9102248e98eed069840ea6d3d23a243fd5 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.12e-06 | 144 | 149 | 6 | 0322fef818a963be00535d5f141f028d43de5c6a | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.49e-06 | 145 | 149 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.19e-05 | 168 | 149 | 6 | 2572a3dd4f3f619bd26a3cd6e60de43821d8bb64 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.19e-05 | 168 | 149 | 6 | 08f6e171a1ea5cf65149744296d0fcd6c7b9684e | |
| ToppCell | CV-Mild-7|CV / Virus stimulation, Condition and Cluster | 2.34e-05 | 170 | 149 | 6 | 25ebde7d2f8ae1afdfaf5876284ff20bb179eb10 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 170 | 149 | 6 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 170 | 149 | 6 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination__)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-05 | 171 | 149 | 6 | d1e87478d8c0329e662849823f5c7604f20e1b1a | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-05 | 173 | 149 | 6 | 50b25b7f8f29b60c22782a4492fe4b089fe7d69d | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 177 | 149 | 6 | 692cd03bf0958ebeec34d41bfe87713a768e9a8e | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 177 | 149 | 6 | c08583ea68bbeb6b5de852a46b0c0f04792dae55 | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 3.54e-05 | 183 | 149 | 6 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 3.54e-05 | 183 | 149 | 6 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-05 | 184 | 149 | 6 | 688428103e8b19f45f2f65d70a0f30c904c8411c | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.65e-05 | 184 | 149 | 6 | fe9ea4d0e0be820e95eaf9bb42a5560d0e177574 | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 3.76e-05 | 185 | 149 | 6 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-05 | 186 | 149 | 6 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.87e-05 | 186 | 149 | 6 | 4fe8e0bf74c7dbf73634cafdacad89020d2634d0 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 3.87e-05 | 186 | 149 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.87e-05 | 186 | 149 | 6 | 7950e03ea080238c168b9d807e217f459acdfb28 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-05 | 186 | 149 | 6 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 187 | 149 | 6 | 028e7d6e1211e123879d2f353dc32fae1185dd8e | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.99e-05 | 187 | 149 | 6 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.99e-05 | 187 | 149 | 6 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Basophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.11e-05 | 188 | 149 | 6 | 3638d85452de15a060146628fbbad9d2a36feb13 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-05 | 188 | 149 | 6 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | MS-CD8-CD4_Treg|MS / Condition, Cell_class and T cell subcluster | 4.11e-05 | 188 | 149 | 6 | 2f0e2c7d79ee2d69a5d908c0247dc950c056c30a | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.23e-05 | 189 | 149 | 6 | b2542b6fcf7bc10d29158d42b03182a939ff135a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.23e-05 | 189 | 149 | 6 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.23e-05 | 189 | 149 | 6 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.36e-05 | 190 | 149 | 6 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.36e-05 | 190 | 149 | 6 | da58227565ad6a690828dd8554dd3670222f8582 | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 4.49e-05 | 191 | 149 | 6 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 193 | 149 | 6 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 193 | 149 | 6 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.76e-05 | 193 | 149 | 6 | 96c85b250d04b5f400512097d925061c6dc2906b | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 193 | 149 | 6 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.76e-05 | 193 | 149 | 6 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | Control-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 4.76e-05 | 193 | 149 | 6 | 3479c01aaae7afd7e02d00e0cb21951c0106a0fd | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-Cycling_T|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.76e-05 | 193 | 149 | 6 | 81e6240cffb094b2aa3684fd0889b6497f47c4f0 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.76e-05 | 193 | 149 | 6 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 193 | 149 | 6 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Sema3e_Kank4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.82e-05 | 118 | 149 | 5 | d7dcffc0476a6e471debd83904a6569c6f27a594 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue | 4.90e-05 | 194 | 149 | 6 | a8ae49157ca3f9e8b3f1750a995aee012dc859b6 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.90e-05 | 194 | 149 | 6 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.90e-05 | 194 | 149 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.90e-05 | 194 | 149 | 6 | 8f4b63b0b9a40765205e4ca6bd94a675a83dbe3d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.90e-05 | 194 | 149 | 6 | 02a9cc821c2b14aa7d0e55661a5fab66364474e1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.04e-05 | 195 | 149 | 6 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.04e-05 | 195 | 149 | 6 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 5.04e-05 | 195 | 149 | 6 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.04e-05 | 195 | 149 | 6 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 5.04e-05 | 195 | 149 | 6 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.04e-05 | 195 | 149 | 6 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.04e-05 | 195 | 149 | 6 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_3|Classical_Monocyte / Disease condition and Cell class | 5.18e-05 | 196 | 149 | 6 | 15397ec27167bb2fb6fec120b68bf38fc71b2670 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.18e-05 | 196 | 149 | 6 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.18e-05 | 196 | 149 | 6 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.18e-05 | 196 | 149 | 6 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_3|COVID-19_Mild / Disease condition and Cell class | 5.18e-05 | 196 | 149 | 6 | f245e929a286cb097130572e1027b4f01be8b04d | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Adventitial_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.18e-05 | 196 | 149 | 6 | eed9fe83ffc1f79493b70778962a671dd9f481e0 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 5.18e-05 | 196 | 149 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.18e-05 | 196 | 149 | 6 | de70cc301a8cbaedb0a5ea4a6442dcdaa477822d | |
| ToppCell | mLN-B_cell-B_cell_cycling|mLN / Region, Cell class and subclass | 5.33e-05 | 197 | 149 | 6 | 806dddcca85c82bd642008d930c8db16b613d88e | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.33e-05 | 197 | 149 | 6 | a4855c5aebea4f0fed4eb035844572e82e5bac46 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.33e-05 | 197 | 149 | 6 | 61c1c29a62d4c033999b7f0183c1e9cdd6a62925 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.33e-05 | 197 | 149 | 6 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | mLN-(2)_B_cell-(24)_B_cell_cycling|mLN / shred on region, Cell_type, and subtype | 5.33e-05 | 197 | 149 | 6 | 70fff2d6723f259e18e7a21d22dc46d71f0759ce | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.33e-05 | 197 | 149 | 6 | b6689a3e01e4c285fc2cb33f8c437078722a3892 | |
| ToppCell | Healthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2) | 5.33e-05 | 197 | 149 | 6 | b6bbf87e5823fa66b4cad6a7be4f777356887b59 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon|organoid_Velasco_nature / Sample Type, Dataset, Time_group, and Cell type. | 5.48e-05 | 198 | 149 | 6 | a6f65bb0845d8f64f5c7edb00cee3ca5adb1a373 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | 5.48e-05 | 198 | 149 | 6 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 5.48e-05 | 198 | 149 | 6 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | Mild-CD8+_T_activated|Mild / Disease group and Cell class | 5.48e-05 | 198 | 149 | 6 | ceac1b51bacfd0dd7fe7c6a666f7927055e1f380 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.48e-05 | 198 | 149 | 6 | 281fc2536cdc4c717b30de156e563c0e4baba99d | |
| Computational | Neighborhood of MSH2 | 8.07e-05 | 28 | 90 | 4 | GNF2_MSH2 | |
| Drug | procarbazine | 2.53e-06 | 93 | 148 | 7 | CID000004915 | |
| Drug | diepoxybutane | 9.24e-06 | 113 | 148 | 7 | CID000011254 | |
| Drug | AC1NDP1U | 1.04e-05 | 115 | 148 | 7 | CID004629339 | |
| Drug | tyrphostin 23 | 1.10e-05 | 116 | 148 | 7 | CID000002052 | |
| Drug | AC1L1IM7 | 1.20e-05 | 46 | 148 | 5 | CID000004638 | |
| Drug | NSC-364372 | BRIP1 IPO8 HECW1 LCP1 FANCM CCNT1 GUF1 TCERG1 FANCI CLTC ANP32A IKBKB USP15 | 1.74e-05 | 484 | 148 | 13 | CID000435143 |
| Drug | triethylamine | 1.82e-05 | 50 | 148 | 5 | CID000008471 | |
| Drug | H 85 | 2.29e-05 | 26 | 148 | 4 | CID006439306 | |
| Disease | Bone marrow hypocellularity | 2.18e-08 | 18 | 145 | 5 | C1855710 | |
| Disease | Fanconi Anemia | 1.31e-07 | 25 | 145 | 5 | C0015625 | |
| Disease | Pancytopenia | 1.62e-07 | 26 | 145 | 5 | C0030312 | |
| Disease | Acute monocytic leukemia | 1.62e-07 | 26 | 145 | 5 | C0023465 | |
| Disease | Miller Dieker syndrome | 2.89e-07 | 29 | 145 | 5 | C0265219 | |
| Disease | Fanconi anemia | 5.39e-07 | 14 | 145 | 4 | cv:C0015625 | |
| Disease | Abnormality of radial ray | 5.68e-07 | 33 | 145 | 5 | C4228778 | |
| Disease | Malignant Head and Neck Neoplasm | 2.49e-06 | 44 | 145 | 5 | C0278996 | |
| Disease | Fanconi anemia (implicated_via_orthology) | 6.39e-06 | 8 | 145 | 3 | DOID:13636 (implicated_via_orthology) | |
| Disease | Fanconi anemia (is_implicated_in) | 1.36e-05 | 10 | 145 | 3 | DOID:13636 (is_implicated_in) | |
| Disease | MYELODYSPLASTIC SYNDROME | 2.02e-05 | 67 | 145 | 5 | C3463824 | |
| Disease | Leukemia, Myelocytic, Acute | 2.21e-04 | 173 | 145 | 6 | C0023467 | |
| Disease | cortical surface area measurement | STAG1 DOCK10 SEMA5A WLS DENND3 TG SULF2 PIK3R1 STAU2 FSHR MLH1 ADAMTS20 GNA12 DAAM1 MCTP2 CNOT4 CCDC33 | 3.40e-04 | 1345 | 145 | 17 | EFO_0010736 |
| Disease | Inflammatory Myofibroblastic Tumor | 3.55e-04 | 6 | 145 | 2 | C0334121 | |
| Disease | platelet component distribution width | SWAP70 KALRN DOCK10 ABCC5 LCP1 GCC2 TLN1 MLH1 GNA12 EIF2AK4 USP15 TGS1 | 3.67e-04 | 755 | 145 | 12 | EFO_0007984 |
| Disease | response to interferon-beta | 4.96e-04 | 7 | 145 | 2 | GO_0035456 | |
| Disease | language measurement | 5.37e-04 | 134 | 145 | 5 | EFO_0007797 | |
| Disease | cerebrospinal fluid clusterin measurement | 6.78e-04 | 35 | 145 | 3 | EFO_0007657 | |
| Disease | tongue squamous cell carcinoma (is_marker_for) | 7.99e-04 | 37 | 145 | 3 | DOID:0050865 (is_marker_for) | |
| Disease | cortical thickness | WLS DENND3 TG SULF2 PIK3R1 STAU2 FSHR ADAMTS20 SNX31 GNA12 DLX5 PLCH1 SGF29 USP15 | 1.21e-03 | 1113 | 145 | 14 | EFO_0004840 |
| Disease | candidiasis (implicated_via_orthology) | 1.33e-03 | 44 | 145 | 3 | DOID:1508 (implicated_via_orthology) | |
| Disease | carbohydrate measurement | 1.51e-03 | 46 | 145 | 3 | EFO_0004998 | |
| Disease | serum gamma-glutamyl transferase measurement | UBR1 BRIP1 STAG1 KALRN GON4L FAM227B PIK3R1 TLN1 MLH1 FUT3 DNMBP CNOT4 | 1.91e-03 | 914 | 145 | 12 | EFO_0004532 |
| Disease | Tobacco Dependence | 2.10e-03 | 14 | 145 | 2 | C0040332 | |
| Disease | Nicotine Dependence | 2.10e-03 | 14 | 145 | 2 | C0028043 | |
| Disease | Nicotine Use Disorder | 2.10e-03 | 14 | 145 | 2 | C0376384 | |
| Disease | S-7-hydroxywarfarin measurement | 2.16e-03 | 110 | 145 | 4 | EFO_0803329 | |
| Disease | left ventricular diastolic function measurement | 2.40e-03 | 54 | 145 | 3 | EFO_0008204 | |
| Disease | cancer biomarker measurement | 2.41e-03 | 15 | 145 | 2 | EFO_0005127 | |
| Disease | leukemia | 2.53e-03 | 55 | 145 | 3 | C0023418 | |
| Disease | antihyperlipidemic drug use measurement | 2.54e-03 | 115 | 145 | 4 | EFO_0803367 | |
| Disease | mean corpuscular hemoglobin concentration | BRIP1 RMND5A SWAP70 KALRN GON4L ABCC5 RRM1 LCP1 FANCG GNA14 PIK3R1 HECW2 EIF2AK4 | 3.22e-03 | 1105 | 145 | 13 | EFO_0004528 |
| Disease | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | 3.88e-03 | 19 | 145 | 2 | EFO_0004612, EFO_0008589 | |
| Disease | ovarian neoplasm | 4.39e-03 | 134 | 145 | 4 | C0919267 | |
| Disease | haptoglobin measurement | 4.74e-03 | 21 | 145 | 2 | EFO_0004640 | |
| Disease | Malignant neoplasm of ovary | 4.74e-03 | 137 | 145 | 4 | C1140680 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FNIIKILNNPRAYTL | 341 | Q96M60 | |
| LYLDANQIEELPKQL | 51 | Q96RT1 | |
| PVEQLLFAYKLLDRA | 721 | Q96N23 | |
| RLENAYRAFVPLLKN | 86 | A6NEN9 | |
| DREKELLLLYQAQQP | 721 | Q8N5R6 | |
| PFARYVARNNILNLK | 1121 | Q9P2K8 | |
| RQELNTLANPFLAKY | 71 | Q9NZD4 | |
| AIQFINQREKPLALY | 351 | P30838 | |
| TFYRQALLDSPLNKE | 1626 | Q8TCU4 | |
| NVFVQLPRLQKLYLD | 236 | P35858 | |
| NYEALNAQLLDELPK | 1156 | Q6XZF7 | |
| TNLNDYRENVFKLLP | 126 | P39687 | |
| PDKELSYRQQAANLL | 31 | O60563 | |
| LELLAYLDKSPQFRN | 851 | Q7Z478 | |
| GQLLNALLDFQNLYK | 571 | A2RUS2 | |
| NLNFLFAPLSKERAQ | 306 | Q8N7R7 | |
| ALQRRFQKTQYLALP | 166 | Q07687 | |
| FQKTQYLALPERAEL | 171 | Q07687 | |
| ALQRRFQKTQYLALP | 151 | P56178 | |
| FQKTQYLALPERAEL | 156 | P56178 | |
| LPKDFMDRNQYALLL | 551 | Q8N608 | |
| KPHLIYRQDLNNSFL | 181 | P59510 | |
| IKLLDSDQELYRNFP | 496 | P25098 | |
| NNSLFLEYSKNPLRE | 636 | Q01432 | |
| RVQLPNNFLKNLEDF | 1516 | Q9ULI1 | |
| NYIFLRNAAEELKPR | 351 | P78406 | |
| DALQYLLQFARKPVE | 51 | Q96HW7 | |
| DQNRVMLKYLFPLNE | 506 | Q8N442 | |
| ALENRKEPAALQYIF | 336 | Q969Q6 | |
| PVDQFQLYQRLKFER | 96 | Q7Z419 | |
| YNDKIVAFLRQPNIF | 1081 | Q9P2P5 | |
| QFYQPKIQQFLRALD | 921 | Q9NVI1 | |
| LLTLFNPDLANNYKR | 1211 | Q9Y4B6 | |
| RDLKPENLLIDQQGY | 166 | P17612 | |
| KLRNPYSIDNNELLD | 831 | Q6DN12 | |
| EFKFPNRLNLEAINY | 106 | P09382 | |
| YPNNLNSVLAERLEK | 261 | O14920 | |
| KRNFEHFLLQYLQPR | 226 | O75648 | |
| LYLDANQIEELPKQL | 51 | Q96NW7 | |
| LETLDLNYNKLQEFP | 236 | Q9HBX8 | |
| LNYNKLQEFPVAIRT | 241 | Q9HBX8 | |
| LLQEFATRKPQYEQL | 4671 | Q03001 | |
| LPLAYNDKIVAFLRQ | 1111 | Q76N89 | |
| KYQIILARDQFRKNP | 331 | Q8IYD8 | |
| KDDLRAYFILLQNPQ | 226 | Q5U5R9 | |
| PNKISALREFLQENY | 721 | Q8NDZ0 | |
| KTYFEDNPRDLQLLR | 461 | Q9NY93 | |
| ELRLALAQPHNFIYK | 76 | Q6X9E4 | |
| KLNLAFIANLFNRYP | 361 | P13796 | |
| NNIFLKELEKYEQLP | 1341 | O60229 | |
| FLNALQSPIEYQRKE | 2231 | O60229 | |
| NPQRALLYLVAALKE | 261 | O15287 | |
| PSDKQRFYTNQLLDV | 306 | Q13568 | |
| FDKSIYNVRLLENAP | 241 | Q9Y5H7 | |
| VLADAFKRYLLDLPN | 181 | P27986 | |
| LLNPFIYSLRNEKVQ | 281 | Q8NGM8 | |
| PEFYKFLQENDQSLL | 81 | Q9Y3T9 | |
| KQLEDLNILFNENPY | 26 | A6NFQ7 | |
| YFLFLNNNFIKRLDP | 111 | Q7Z2Q7 | |
| FPNVKDLQVELKRQY | 786 | Q9BX63 | |
| RYQELLDDNQAPFFL | 1076 | O15440 | |
| LDFQLQDPFLLYRNA | 91 | Q8IZD4 | |
| NKYPSVLNLNEELRD | 866 | Q9Y4D1 | |
| DIQLKYFDLGLPNRD | 76 | P48735 | |
| NLLIKFDPSYRNDLN | 1121 | Q4G0P3 | |
| RLLKNDPVNLQKFSY | 11 | Q8TE85 | |
| RDLKPENLLIDQQGY | 166 | P22612 | |
| EKTYRNDPLQDLLFF | 61 | Q96BY6 | |
| QFNPKTYEERINLIL | 436 | Q9Y223 | |
| RPGFEEQILYLQKQL | 191 | Q8IWJ2 | |
| PLREQKDLAFAQAYL | 1621 | Q3T8J9 | |
| QLNYFPSKQDILLAR | 191 | Q03113 | |
| FNNYRLFPRLQKLLE | 56 | Q96HE7 | |
| AIRLNPDNQYLKVLL | 201 | P09913 | |
| ERIFTKLSYPQDNLQ | 676 | Q17RS7 | |
| LLNQLKSFPARLRQY | 1366 | Q14204 | |
| QLEALENLFQETKYP | 171 | P56915 | |
| GNLYLNDSPLKNFRI | 506 | Q8IW92 | |
| LARADFQKVLQLYPN | 371 | Q02790 | |
| RIEKANNLLYINPEA | 101 | P23945 | |
| AAQYPELNALQEELK | 76 | P59796 | |
| FNLRELLPKQLGQYF | 196 | Q9ULX7 | |
| APYRQQLKIINDLLA | 941 | P51530 | |
| LDNISPQQIRKLFYV | 521 | Q9BXW9 | |
| PKLRIAAENELNQSY | 16 | O15397 | |
| FQSPKDLARYLQELD | 296 | P21217 | |
| ARDFILKLYQDQNPD | 301 | O95837 | |
| FQLPLRFDLQYKGQA | 561 | Q9BW92 | |
| SQIYNIDPARFKDLN | 281 | Q9NP81 | |
| PQLDYVFTLAQNLKN | 2281 | P46939 | |
| LLALLNKNFDFQRPF | 51 | Q765I0 | |
| KNNPDLYLKELLNLA | 86 | Q6P1N9 | |
| REALQYAKNFQPFAL | 211 | Q9H871 | |
| FVKENLVKLLNPRYN | 96 | O75674 | |
| RKRPNQALLENIALY | 536 | P49589 | |
| YEKIQPLLENLHRNF | 101 | Q8IYX1 | |
| NYFNVIPKVAFLRLN | 231 | O60938 | |
| LFALQNLFEEKYAPR | 206 | Q99707 | |
| QNPKDFQNLLSVYLD | 151 | Q5JRX3 | |
| LFDIKPEQQRYSLFL | 86 | O95707 | |
| PNLAFIRLNYNKLTD | 266 | P51888 | |
| QEAEEFLYRFLPQKI | 26 | Q9UL46 | |
| LQLANLPDLYKVFER | 741 | P40692 | |
| AAPQRQAYLKFLDQF | 211 | Q8WZ82 | |
| NVLPRDLFQKLFRQD | 326 | Q8N122 | |
| KAYLDIFLPNEQSIR | 116 | Q8N9S9 | |
| NLILEERNKYFNPHL | 1041 | Q13591 | |
| QFKDHPTLNDRYLLL | 451 | Q86UE8 | |
| LLKYQDQDFLPRDQH | 441 | Q0P6D6 | |
| KIYIDSNNNPERFLR | 881 | Q00610 | |
| RAIQFYLEFKPLLLN | 1406 | Q00610 | |
| LKEVRFFNLQSLYPL | 176 | Q8NCG5 | |
| LDEKFPQDYRLAQQV | 801 | Q15021 | |
| LQELYKLNPNFLQLS | 241 | O95628 | |
| FDPRYLLLNSEERKQ | 481 | Q5VWI1 | |
| SFIENNRLYLPKNEL | 501 | P56180 | |
| ALSLKPNDALVYNFR | 476 | Q86TZ1 | |
| EFYNGPNRNRLLLKS | 261 | O15374 | |
| LARFNRVQPQYKLLN | 16 | Q9NUL3 | |
| NINYVPLKFRVLFAN | 166 | Q9NR77 | |
| EPNRNEYLELKAKLN | 926 | O94991 | |
| LLNPKERKQVFDQYV | 696 | O14776 | |
| RYPFESAEAQLLNKQ | 516 | P23921 | |
| ALFQKEQLVLALYPQ | 226 | Q96ES7 | |
| RQQQYKFLPSELRDE | 2526 | Q9Y490 | |
| AELLDLSKQYDQQFP | 6 | O75558 | |
| IYPNEGFLKQLRELN | 261 | Q5VZP5 | |
| ILLENQLFPDNFAKR | 111 | Q9Y4K3 | |
| EDRKFAPQIRVNLNY | 46 | Q9Y5S1 | |
| LEVLPEYLDRNNKFN | 446 | Q8IWV7 | |
| AVPRNNTEDKLYNLL | 596 | Q9Y4E8 | |
| NTKARLLYEANLPEN | 91 | Q8IYB5 | |
| AEKVANLLQIPQYFD | 586 | Q8WVM7 | |
| LNKNNLIPDDRANFY | 1101 | Q9P283 | |
| QLRTDKNYSFPLNNL | 501 | Q96JH7 | |
| LYSKQDANQLPRALV | 1561 | Q4KWH8 | |
| LRPSANVYDLAKNFN | 1036 | Q9P2E3 | |
| DLNIQQNSKYPILFL | 641 | Q8NET8 | |
| EEKPLQIQNDYLFQL | 486 | O60346 | |
| YTDRVKPLQDQNELF | 196 | Q12874 | |
| PYLNRFILEKVQDNF | 71 | Q9UH65 | |
| VAYAKLRNPFVINDL | 111 | O43314 | |
| KITNNIVYFLPRNAD | 796 | Q96RS0 | |
| AHKFYLLNIRLPVNE | 191 | Q5T9L3 | |
| KFENLLNVLEYLALQ | 106 | Q3SY77 | |
| KDFLEVLINLRNPNY | 156 | Q8N5T2 | |
| NYKEFSELLPNRQGL | 2696 | P01266 | |
| QEENFLPKYQRVKDL | 431 | Q8IWU5 | |
| KLRNPFLINDLAMQY | 126 | Q6PFW1 | |
| LRALFQYKPQNVDEL | 281 | P57075 | |
| VDNVGFNRLLEYLKP | 676 | O75132 | |
| AFPAYLLGINQDRLK | 306 | Q12965 | |
| PNADLAYNSLKRQEL | 1191 | Q9ULV0 | |
| VNLARLAINYDPLEK | 76 | Q86TC9 |